Unlike traditional metabolic research compounds, Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, making it one of the most advanced tools available for studying metabolism, energy balance, appetite regulation, and fat oxidation pathways
Double-blind, placebo-controlled, randomized trial of selenium in graves hyperthyroidism
Protein Staples (Start Here First) If there is one area to prioritize on GLP-1s, its protein
Clinical development timeline Eli Lilly Phase 3 TRIUMPH program is the most extensive clinical development program for retatrutide
Dimensions: 4000 x 2667 px | 33.9 x 22.6 cm | 13.3 x 8.9 inches | 300dpi Date taken: 16 November 2025 Photographer: Sipa USA More information: This image could have imperfections as its either historical or reportage.
While these side effects are often mild, they still warrant attention, especially with extended use